
Advancing Myelofibrosis Care: Balancing Clinical Innovation With Economic Impact
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Virtual care replaces, not adds, Medicare visits for health systems, analysis shows
2
FDA approves $2.59 million gene therapy for SMA
3
Optum Rx removes reauthorizations from an additional 40 drugs
4
CMS negotiates a 70% discount for Ozempic and Wegovy
5



